CoChat
Sign Up
Cited by 132Pharmaceutical Practices and Patient OutcomesOpioid Use Disorder TreatmentMental Health Treatment and Access

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies

Petitjean, Sylvie, Ladewig, Dieter, Meier, Christoph R., Amrein, Roman, Wiesbeck, Gerhard A.·2007·International Clinical Psychopharmacology
DOI 10.1097/yic.0b013e328105e0f2
Open this paper in CoChat — free account

Abstract

UNLABELLED: The purpose of the study was to assess prevalence of benzodiazepine use in the Swiss adult population and to assess on benzodiazepine prescription patterns of physicians in domiciliary practice. STUDY DESIGN: A retrospective, population-based cross-sectional study with 520 000 patients covering a 6-month period. METHODS: We estimated the prevalence, amount and duration of benzodiazepine use using a pharmacy dispensing database. RESULTS: Of all patients, 9.1% (n=45 309) received at least one benzodiazepine prescription in the 6-month period. Most persons receiving benzodiazepine prescriptions were women (67%), and half of all patients were aged 65 or older. Of 45 309 patients with benzodiazepine prescriptions, 44% (n=19 954) had one single prescription, mostly for a short period (<90 days) and in lower than the recommended dose range. Fifty-six percent (n=25 354) had repeated benzodiazepine prescriptions, mostly for a long time period (>90 days), and in lower than the recommended or within the recommended dose range. In patients with long-term use (n=25 354), however, 1.6% had benzodiazepine prescriptions in extremely high doses. The sample of patients with repeated prescriptions allowed an estimation of a benzodiazepine use of 43.3 daily defined doses per 1000 inhabitants in Switzerland. CONCLUSIONS: Benzodiazepine prescriptions were appropriate for most patients and thus were prescribed in therapeutic doses, as indicated in the treatment guidelines. On the other hand, our survey showed that 1.6% of the patients had prescriptions for long time periods at very high doses, indicating an abuse or dependence on benzodiazepines in this subgroup.

Overview

Integrity signals

Registry

Crossref · 10.1097/yic.0b013e328105e0f2

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 22 references

Research works printed but not linked: 8

  1. Busto, 1989, CMAJ, 141, 917
  2. Garc??a del Pozo, 2004, Rev Esp Salud P??blica, 78, 379
  3. Ladewig, 1990, Schweiz Apotheker-Zeitung, 128, 100
  4. Laux, 1995, Nervenarzt, 66, 311
  5. McLeod, 1997, CMAJ, 156, 385
  6. Tamblyn, 1994, CMAJ, 150, 1801
  7. Woods, 1992, Pharmacol Rev, 44, 151
  8. Zwar, 2000, Aust Fam Physician, 29, 1104

Cited by

Sorted by citations

Items 101–131 of 131

Related

See all

Metadata

Authors
Petitjean, S., Ladewig, D., Meier, C. R., Amrein, R., & Wiesbeck, G. A.
Affiliations
  • Universitäre Psychiatrische Kliniken Basel (CH)
  • University Hospital of Basel (CH)
Corresponding author
Petitjean, Sylvie
ORCID
Meier, Christoph R.
Venue
International Clinical Psychopharmacology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2007-09
Volume
22
Issue
5
Pages
292-298
ISSN
0268-1315 (ISSN-L)
DOI
10.1097/yic.0b013e328105e0f2
OpenAlex
W2053311281
Cited by
132
References
22
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 7 · 2021: 11 · 2020: 22 · 2019: 7 · 2018: 11 · 2017: 9 · 2016: 10 · 2015: 11 · 2014: 6 · 2013: 5 · 2012: 6
FWCI
1.76
Type
journal article
Language
en
Open access
closed
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Bundesamt für Gesundheit
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
benzodiazepines, benzodiazepine prescribing, prescribing patterns, benzodiazepine misuse, benzodiazepine dependence, long-term benzodiazepine use, community pharmacy dispensing
MeSH terms
Adolescent, Adult, Aged, Benzodiazepines, Cross-Sectional Studies, Dose-Response Relationship, Drug, Drug Utilization, Female, Health Surveys, Humans, Male, Middle Aged, Pharmacies, Drug Prescriptions, Retrospective Studies, Switzerland

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review